In this issue:
Dasatinib-blinatumomab for Philadelphia-positive ALL
Allogeneic HCT for transplant-eligible ALL/LBL
Multicolour flow cytometry for circulating lymphoma cells
Splenic marginal zone lymphoma survival analysis
Relapsed/refractory diffuse large B-cell lymphoma outcomes
Outcomes in patients with DLBCL treated with CAR T-cells
Non-myeloablative allogeneic transplantation for cutaneous T-cell lymphoma
Obinutuzumab/cytarabine induction for untreated MCL
Pre-emptive intervention in AML with NPM1
Chemotherapy and venetoclax in elderly AML
Please login below to download this issue (PDF)